XBIOTECH INC's ticker is and the CUSIP is 98400H952. A total of 3 filers reported holding XBIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $23,000 | +283.3% | 4,000 | +700.0% | 0.00% | – |
| Q3 2021 | $6,000 | -95.2% | 500 | -93.3% | 0.00% | – |
| Q2 2021 | $124,000 | +20.4% | 7,500 | +25.0% | 0.00% | – |
| Q1 2021 | $103,000 | +543.8% | 6,000 | +500.0% | 0.00% | – |
| Q4 2020 | $16,000 | -98.8% | 1,000 | -98.5% | 0.00% | -100.0% |
| Q3 2020 | $1,302,000 | +49.1% | 68,200 | +7.1% | 0.00% | 0.0% |
| Q2 2020 | $873,000 | +18.9% | 63,700 | -7.8% | 0.00% | -33.3% |
| Q1 2020 | $734,000 | +244.6% | 69,100 | +506.1% | 0.01% | +500.0% |
| Q4 2019 | $213,000 | -41.8% | 11,400 | -67.4% | 0.00% | -66.7% |
| Q3 2019 | $366,000 | +41.9% | 35,000 | +2.9% | 0.00% | +50.0% |
| Q2 2019 | $258,000 | -24.8% | 34,000 | +9.3% | 0.00% | -50.0% |
| Q1 2019 | $343,000 | +161.8% | 31,100 | +20.5% | 0.00% | +300.0% |
| Q4 2018 | $131,000 | -6.4% | 25,800 | -41.4% | 0.00% | 0.0% |
| Q3 2018 | $140,000 | -15.2% | 44,000 | +19.6% | 0.00% | 0.0% |
| Q2 2018 | $165,000 | -8.3% | 36,800 | +9.5% | 0.00% | -50.0% |
| Q1 2018 | $180,000 | +21.6% | 33,600 | -10.4% | 0.00% | +100.0% |
| Q4 2017 | $148,000 | -54.9% | 37,500 | -50.0% | 0.00% | -66.7% |
| Q3 2017 | $328,000 | +404.6% | 75,000 | +439.6% | 0.00% | +200.0% |
| Q2 2017 | $65,000 | -54.5% | 13,900 | +59.8% | 0.00% | -50.0% |
| Q1 2017 | $143,000 | +266.7% | 8,700 | +123.1% | 0.00% | – |
| Q4 2016 | $39,000 | +77.3% | 3,900 | +143.8% | 0.00% | – |
| Q3 2016 | $22,000 | – | 1,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIMPLEX TRADING, LLC | 100 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 4,000 | $23,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |